PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Capsaicin→

Capsaicin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
404-86-4
Molecular formula
C18H27NO3
Molecular weight
305.4 g/mol
Drug class
Transient receptor potential vanilloid 1 (TRPV1) agonisttopical analgesic
Mechanism of action
Initially activates TRPV1 receptors on peripheral nociceptive neurons, causing local warmth or burning. Repeated exposure leads to functional desensitisation and reduced release of pain-related neuropeptides, lowering peripheral nociceptive signalling.
Indications / reported uses
  • Topical relief of neuropathic pain, including postherpetic neuralgia and painful diabetic peripheral neuropathy, using the product-specific strength
  • Temporary relief of minor muscle and joint pain with lower-strength topical preparations; high-concentration patches require supervised application

Sources: US DailyMed — Capsaicin topical products · US FDA prescribing information — QUTENZA · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Capsaicin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Capsaicin Permitted Daily Exposure (PDE) report (the Capsaicin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Capsaicin Occupational Exposure Limit (OEL) report (the Capsaicin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.